Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LN
3776
CALL
DELISTED
LINE Corporation
LN
| $1.74M | ﹤0.01% |
+35,900
| New | +$1.53M |
|
3777
CALL
IQVIA
IQV
$43.1B
| $1.74M | ﹤0.01% |
21,400
-25,800
| -55% | -$1.95M |
|
3778
CALL
Comscore
SCOR
$78.4M
| $1.74M | ﹤0.01% |
2,830
-1,760
| -38% | -$998K |
|
|
LOGM
3779
PUT
DELISTED
LogMein, Inc.
LOGM
| $1.74M | ﹤0.01% |
19,200
+7,400
| +63% | +$593K |
|
3780
Capitol Federal Financial
CFFN
$1.07B
| $1.73M | ﹤0.01% |
123,200
-41,094
| -25% | -$581K |
|
3781
PUT
Rockwell Medical
RMTI
$32.9M
| $1.73M | ﹤0.01% |
2,350
+429
| +22% | +$347K |
|
|
FLXN
3782
CALL
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $1.73M | ﹤0.01% |
88,600
+60,600
| +216% | +$1.03M |
|
|
IMOS
3783
CALL
ChipMOS TECHNOLOGIES
IMOS
$1.93B
| $1.73M | ﹤0.01% |
79,137
+22,961
| +41% | +$475K |
|
|
IDTI
3784
DELISTED
Integrated Device Technology I
IDTI
| $1.73M | ﹤0.01% |
+74,773
| New | +$1.54M |
|
3785
C.H. Robinson
CHRW
$17.6B
| $1.73M | ﹤0.01% |
24,500
-50,100
| -67% | -$3.51M |
|
3786
Cal-Maine
CALM
$3.75B
| $1.72M | ﹤0.01% |
+44,742
| New | +$1.93M |
|
|
EEP
3787
PUT
DELISTED
Enbridge Energy Partners
EEP
| $1.72M | ﹤0.01% |
67,800
+45,400
| +203% | +$1.09M |
|
3788
Jack in the Box
JACK
$311M
| $1.72M | ﹤0.01% |
+17,960
| New | +$1.7M |
|
3789
iShares MSCI Austria ETF
EWO
$209M
| $1.72M | ﹤0.01% |
105,527
+26,462
| +33% | +$406K |
|
|
JPNL
3790
DELISTED
Direxion Daily Japan Bull 3x Shares
JPNL
| $1.72M | ﹤0.01% |
37,863
+8,225
| +28% | +$347K |
|
3791
Direxion Daily MSCI India Bull 2X ETF
INDL
$56.2M
| $1.72M | ﹤0.01% |
29,350
+10,301
| +54% | +$598K |
|
3792
PUT
BOK Financial
BOKF
$8.35B
| $1.72M | ﹤0.01% |
24,900
-85,300
| -77% | -$5.66M |
|
|
ADAM
3793
Adamas Trust
ADAM
$881M
| $1.72M | ﹤0.01% |
71,245
+10,614
| +18% | +$262K |
|
3794
PUT
Sempra
SRE
$55.1B
| $1.72M | ﹤0.01% |
32,000
-17,000
| -35% | -$925K |
|
3795
iShares MSCI Netherlands ETF
EWN
$723M
| $1.71M | ﹤0.01% |
68,412
+40,833
| +148% | +$989K |
|
3796
PUT
Travere Therapeutics
TVTX
$6.19B
| $1.71M | ﹤0.01% |
76,600
-90,300
| -54% | -$1.72M |
|
|
GASL
3797
PUT
DELISTED
Direxion Daily Natural Gas Related Bull 3X Shares
GASL
| $1.71M | ﹤0.01% |
71
+16
| +29% | +$347K |
|
3798
CALL
VanEck High Yield Muni ETF
HYD
$4.33B
| $1.71M | ﹤0.01% |
+26,550
| New | +$1.71M |
|
3799
PUT
British American Tobacco
BTI
$121B
| $1.71M | ﹤0.01% |
26,800
-18,400
| -41% | -$1.17M |
|
3800
PUT
MGIC Investment
MTG
$6.36B
| $1.71M | ﹤0.01% |
213,800
+135,400
| +173% | +$1.01M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.